Stellate Ganglion Block in Longstanding Facial Nerve Palsy Patients
1 other identifier
observational
34
0 countries
N/A
Brief Summary
The goal of the present study is to verify the efficacy of stellate ganglion block (SGB) in the treatment of facial pain
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2024
CompletedFirst Posted
Study publicly available on registry
December 19, 2024
CompletedStudy Start
First participant enrolled
December 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2024
CompletedDecember 19, 2024
December 1, 2024
Same day
December 16, 2024
December 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary outcome: Average motor conduction latency in six muscle of the face
6 month
Secondary Outcomes (1)
Improved muscle tone
6 months
Study Arms (2)
stellate ganglion block group
medical treatment group
Interventions
Stellate ganglion block is an injection of local anesthetic at the level of the neck to target the stellate ganglion, a sympathetic ganglion to interrupt abnormal autonomically-mediated pain in patients resistant to medical treatment
Eligibility Criteria
facial nerve palsy patients
You may qualify if:
- facial nerve palsy patients
You may not qualify if:
- light of a recent myocardial infarction.
- anticoagulant use
- glucoma
- lateral nerve palsy
- emphysema
- cardiac conduction abnormalities
- active infection, flu, cold
- uncontrolled cough
- Fever
- Very high blood pressure or if you are on blood thinners.
- allergic reaction to local anesthetics
- Primary and secondary coagulopathy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (5)
Piraccini E, Munakomi S, Chang KV. Stellate Ganglion Blocks. 2023 Aug 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK507798/
PMID: 29939575BACKGROUNDWang D. Image Guidance Technologies for Interventional Pain Procedures: Ultrasound, Fluoroscopy, and CT. Curr Pain Headache Rep. 2018 Jan 26;22(1):6. doi: 10.1007/s11916-018-0660-1.
PMID: 29374352BACKGROUNDKapral S, Krafft P, Gosch M, Fleischmann D, Weinstabl C. Ultrasound imaging for stellate ganglion block: direct visualization of puncture site and local anesthetic spread. A pilot study. Reg Anesth. 1995 Jul-Aug;20(4):323-8.
PMID: 7577781BACKGROUNDAbdi S, Zhou Y, Patel N, Saini B, Nelson J. A new and easy technique to block the stellate ganglion. Pain Physician. 2004 Jul;7(3):327-31.
PMID: 16858470BACKGROUNDBaig S, Moon JY, Shankar H. Review of Sympathetic Blocks: Anatomy, Sonoanatomy, Evidence, and Techniques. Reg Anesth Pain Med. 2017 May/Jun;42(3):377-391. doi: 10.1097/AAP.0000000000000591.
PMID: 28272291BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident at anesthesia, intensive care and pain management, at Assiut University
Study Record Dates
First Submitted
December 16, 2024
First Posted
December 19, 2024
Study Start
December 20, 2024
Primary Completion
December 20, 2024
Study Completion
December 20, 2024
Last Updated
December 19, 2024
Record last verified: 2024-12